首页 | 本学科首页   官方微博 | 高级检索  
检索        


Mutational founder effect in recessive dystrophic epidermolysis bullosa families from Southern Tunisia
Authors:Ahlem Sabrine Ben Brick  Nadia Laroussi  Hela Mesrati  Rym Kefi  Mbarka Bchetnia  Khaled Lasram  Nizar Ben Halim  Lilia Romdhane  Houyem Ouragini  Salaheddine Marrakchi  Mohamed Samir Boubaker  Mounira Meddeb Cherif  Daniele Castiglia  Alain Hovnanian  Sonia Abdelhak  Hamida Turki
Institution:1. Biomedical Genomics and Oncogenetics Laboratory (LR11IPT 05), Institut Pasteur de Tunis, Université El Manar de Tunis, 13, Place Pasteur, BP74, 1002, Tunis, Tunisia
2. Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia
3. Laboratory of Medical Genetics, Tunis, Tunisia
4. Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell’Immacolata-IRCCS, Rome, Italy
5. INSERM, U781, Paris, France
6. Institut Imagine, University Paris Descartes, Sorbonne Paris Cité, Paris, France
7. Department of Genetics, Necker Hospital, Paris, France
Abstract:Dystrophic epidermolysis bullosa (DEB) is a group of heritable bullous skin disorders caused by mutations in the COL7A1 gene. One of the most severe forms of DEB is the severe generalized recessive dystrophic epidermolysis bullosa (RDEB-SG)] subtype, which is inherited in an autosomal recessive manner. This subtype is most often due to COL7A1 mutations resulting in a premature termination codon on both alleles. We report here, the molecular investigation of 15 patients belonging to 14 nuclear families from the city of Sfax in Southern Tunisia, with clinical features of RDEB-SG complicated by squamous cell carcinoma in 3 patients. We identified two novel mutations, p.Val769LeufsX1 and p.Ala2297SerfsX91, in addition to one previously reported mutation (p.Arg2063Trp). The p.Val769LeufsX1 mutation was shared by 11 families and haplotype analysis indicated that it is a founder mutation. The p.Ala2297SerfsX91 mutation was a private mutation found in only one family. Together with the previously described recurrent mutations in Tunisia, screening for the founder p.Val769LeufsX1 mutation should provide a rapid molecular diagnosis tool for mutation screening in RDEB patients from Southern Tunisia and possibly from other Mediterranean populations sharing the same genetic background.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号